Of course, for these patients it is mandatory that diagnostic criteria of CF are fulfilled and that direct measures demonstrate missing CFTR activity corrected by ex vivo drug screen to predict the best individual treatment. The gene discussed is CFTR; the disease is cystic fibrosis.